Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02817698 · ClinicalTrials.gov registry record · Early Phase 1
Imaging the Neurochemistry of Drug Addiction With PET
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT02817698 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 25 participants.
The verdict
NCT02817698, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The investigators' project has two overarching goals. 1) The investigators will use newly developed positron emission tomography (PET) technology to investigate the dopaminergic neurochemistry of drugs of abuse including marijuana, traditional cigarettes, and cocaine, and 2) The investigators will extend PET technology to an additional neurotransmitter system - namely, the opioid-ergic system, using the same drugs of abuse.
Interventions
- DRUG cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-11-29 |
| Est. Completion | 2024-06-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02817698
The ClinicalTrials.gov registry entry for NCT02817698 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cannabis is the first listed.
NCT02817698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02817698 about?
NCT02817698 is a clinical study titled "Imaging the Neurochemistry of Drug Addiction With PET". The investigators' project has two overarching goals. 1) The investigators will use newly developed positron emission tomography (PET) technology to investigate the dopaminergic neurochemistry of drugs of abuse including marijuana, traditional cigarettes, and cocaine, and 2) The investigators will e...
What is the current status of trial NCT02817698?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2017-11-29. Estimated completion is 2024-06-14.
What interventions are being tested in trial NCT02817698?
The interventions under investigation include: cannabis (DRUG).
Who is sponsoring clinical trial NCT02817698?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.